This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
SP342A SINGLE 1000 MG INFUSION OF IRON ISOMALTOSIDE 1000 DEMONSTRATES A MORE RAPID HEMOGLOBIN RESPONSE AND REDUCED RISK OF CARDIO-VASCULAR ADVERSE EVENTS COMPARED TO MULTIPLE DOSES OF IV IRON SUCROSE IN THE FERWON TRIALS. (13th June 2019)
Record Type:
Journal Article
Title:
SP342A SINGLE 1000 MG INFUSION OF IRON ISOMALTOSIDE 1000 DEMONSTRATES A MORE RAPID HEMOGLOBIN RESPONSE AND REDUCED RISK OF CARDIO-VASCULAR ADVERSE EVENTS COMPARED TO MULTIPLE DOSES OF IV IRON SUCROSE IN THE FERWON TRIALS. (13th June 2019)
Main Title:
SP342A SINGLE 1000 MG INFUSION OF IRON ISOMALTOSIDE 1000 DEMONSTRATES A MORE RAPID HEMOGLOBIN RESPONSE AND REDUCED RISK OF CARDIO-VASCULAR ADVERSE EVENTS COMPARED TO MULTIPLE DOSES OF IV IRON SUCROSE IN THE FERWON TRIALS